United Kingdom Holding Companies

Achilles Therapeutics PLC (ACHL)

Track

Track

Ticker: ACHL Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.0
Coutts Robert William Officer Officer
Transaction date
Proposed sale
Price
456.70
Quantity 48,760
Value US$4,620,679
Ali Iraj Director Non-Executive Director
Transaction date
Proposed sale
Price
29.20
Quantity 66,388
Value US$4,136,016
2.0
Coutts Robert William Officer Officer
Transaction date
Proposed sale
Price
96.92
Quantity 83,617
Value US$574,033
Ehmer Bernhard Director; Former Director Non-Executive Director
Transaction date
Proposed sale
Price
1.38
Quantity 38,750
Value US$53,537
Moses Edwin Director Non-Executive Director
Transaction date
Proposed sale
Price
1.38
Quantity 25,000
Value US$34,500
2.0
Coutts Robert William Officer Officer
Transaction date
Proposed sale
Price
1.23
Quantity 75,024
Value US$91,956
3.0
Giordano Michael F Former Director Non-Executive Director
Transaction date
Proposed sale
Price
1.39
Quantity 25,000
Value US$34,815
BOESS CARSTEN Director Non-Executive Director
Transaction date
Proposed sale
Price
1.36
Quantity 25,000
Value US$34,004
O'Neill Julie Former Director Non-Executive Director
Transaction date
Proposed sale
Price
1.37
Quantity 13,750
Value US$18,857
O'Neill Julie Former Director Non-Executive Director
Transaction date
Proposed sale
Price
1.37
Quantity 25,000
Value US$34,250
Ali Iraj Director Non-Executive Director
Transaction date
Proposed sale
Price
1.19
Quantity 246
Value US$292
Ali Iraj Director Non-Executive Director
Transaction date
Proposed sale
Price
1.17
Quantity 68,814
Value US$80,621
Ali Iraj Director Non-Executive Director
Transaction date
Proposed sale
Price
1.29
Quantity 50,000
Value US$64,337
Ali Iraj Director Non-Executive Director
Transaction date
Proposed sale
Price
1.29
Quantity 50,000
Value US$64,453
Quezada Sergio Andres Former Officer Officer
Transaction date
Proposed sale
Price
1.37
Quantity 67,437
Value US$92,265
Peggs Karl Stuart Dr Officer Officer
Transaction date
Proposed sale
Price
0.93
Quantity 30,000
Value US$27,900
Peggs Karl Stuart Dr Officer Officer
Transaction date
Proposed sale
Price
0.86
Quantity 35,000
Value US$30,100
Peggs Karl Stuart Dr Officer Officer
Transaction date
Proposed sale
Price
0.94
Quantity 35,000
Value US$32,735
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-03 2025-03-03 PrS Proposed sale
2.0
Coutts Robert William

Officer

Officer
48,760
456.70
US$4,620,679 		48,760 456.70 US$4,620,679
2025-03-03 2025-03-03 PrS Proposed sale
Ali Iraj

Director

Non-Executive Director
66,388
29.20
US$4,136,016 		66,388 29.20 US$4,136,016
2025-02-18 2025-02-13 PrS Proposed sale
2.0
Coutts Robert William

Officer

Officer
83,617
96.92
US$574,033 		83,617 96.92 US$574,033
2025-02-11 2025-02-06 PrS Proposed sale
Ehmer Bernhard

Director; Former Director

Non-Executive Director
38,750
1.38
US$53,537 		38,750 1.38 US$53,537
2025-02-07 2025-02-06 PrS Proposed sale
Moses Edwin

Director

Non-Executive Director
25,000
1.38
US$34,500 		25,000 1.38 US$34,500
2025-02-05 2025-02-05 PrS Proposed sale
2.0
Coutts Robert William

Officer

Officer
75,024
1.23
US$91,956 		75,024 1.23 US$91,956
2025-02-06 2025-02-04 PrS Proposed sale
3.0
Giordano Michael F

Former Director

Non-Executive Director
25,000
1.39
US$34,815 		25,000 1.39 US$34,815
2025-02-06 2025-02-04 PrS Proposed sale
BOESS CARSTEN

Director

Non-Executive Director
25,000
1.36
US$34,004 		25,000 1.36 US$34,004
2025-02-06 2025-02-04 PrS Proposed sale
O'Neill Julie

Former Director

Non-Executive Director
13,750
1.37
US$18,857 		13,750 1.37 US$18,857
2025-02-06 2025-02-04 PrS Proposed sale
O'Neill Julie

Former Director

Non-Executive Director
25,000
1.37
US$34,250 		25,000 1.37 US$34,250
2025-02-06 2025-02-04 PrS Proposed sale
Ali Iraj

Director

Non-Executive Director
246
1.19
US$292 		246 1.19 US$292
2025-02-06 2025-02-04 PrS Proposed sale
Ali Iraj

Director

Non-Executive Director
68,814
1.17
US$80,621 		68,814 1.17 US$80,621
2025-02-06 2025-02-04 PrS Proposed sale
Ali Iraj

Director

Non-Executive Director
50,000
1.29
US$64,337 		50,000 1.29 US$64,337
2025-02-06 2025-02-04 PrS Proposed sale
Ali Iraj

Director

Non-Executive Director
50,000
1.29
US$64,453 		50,000 1.29 US$64,453
2025-02-05 2025-02-04 PrS Proposed sale
Quezada Sergio Andres

Former Officer

Officer
67,437
1.37
US$92,265 		67,437 1.37 US$92,265
2024-02-01 2024-02-01 PrS Proposed sale
Peggs Karl Stuart Dr

Officer

Officer
30,000
0.93
US$27,900 		30,000 0.93 US$27,900
2023-11-01 2023-11-01 PrS Proposed sale
Peggs Karl Stuart Dr

Officer

Officer
35,000
0.86
US$30,100 		35,000 0.86 US$30,100
2023-08-17 2023-08-17 PrS Proposed sale
Peggs Karl Stuart Dr

Officer

Officer
35,000
0.94
US$32,735 		35,000 0.94 US$32,735
Explore more

More insider trading research around Achilles Therapeutics PLC

More insider trades in United Kingdom
Similar Financials companies with insider activity
More Holding Companies companies with insider activity
More Holding Companies companies with insider activity
Insider trading in Europe